Arcus Biosciences (RCUS) Return on Capital Employed [ROCE] (2018 - 2026)
Arcus Biosciences (RCUS) reported Return on Capital Employed [ROCE] of -63.74% for Q2 2026, down 26.41 percentage points from -37.33% a year earlier and down 17.40 percentage points from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends
For FY2025, Arcus Biosciences posted Return on Capital Employed [ROCE] of -42.26%, down 5.45 percentage points from FY2024.
- Return on Capital Employed [ROCE] has declined for four consecutive years, with a five-year change of -8.38 percentage points (FY2020 to FY2025).
- By year, Return on Capital Employed [ROCE] came in at -36.81% in FY2024 (-3.99 pp), -32.82% in FY2023 (-10.87 pp), -21.95% in FY2022 (-27.27 pp) and 5.31% in FY2021 (+39.19 pp).
- The Q2 2026 figure ranks as the lowest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2018.
- Year over year, Return on Capital Employed [ROCE] has now declined in each of the last six quarters, with an average year-over-year change of -10.16 percentage points over the last eight quarters.
- The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2022 (a gain of 44.36 percentage points); the low point was Q3 2023 (a drop of 38.09 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -46.33% (Q1 2026), -46.76% (Q4 2025) and -47.50% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Arcus Biosciences | 3.11 Bn | -229.58 Mn | - | -63.74% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -63.74% |
| Mar 31, 2026 | -46.33% |
| Dec 31, 2025 | -46.76% |
| Sep 30, 2025 | -47.50% |
| Jun 30, 2025 | -37.33% |
| Mar 31, 2025 | -45.37% |
| Dec 31, 2024 | -33.85% |
| Sep 30, 2024 | -31.67% |
| Jun 30, 2024 | -28.16% |
| Mar 31, 2024 | -27.27% |
| Dec 31, 2023 | -35.45% |
| Sep 30, 2023 | -32.12% |
| Jun 30, 2023 | -29.61% |
| Mar 31, 2023 | -26.68% |
| Dec 31, 2022 | -23.80% |
| Sep 30, 2022 | 5.96% |
| Jun 30, 2022 | 4.97% |
| Mar 31, 2022 | 4.25% |
| Dec 31, 2021 | 5.14% |
| Sep 30, 2021 | -38.39% |
API Access
Arcus Biosciences Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();